uniQure (QURE) Return on Capital Employed (2017 - 2026)
uniQure (QURE) recorded quarterly Return on Capital Employed of 7.58% in Q1 2026, down 20.57% quarter-over-quarter from 6.28% in Q4 2025, and up 2352.0% on a YoY basis from 0.31% in Q1 2025.
uniQure (QURE) Return on Capital Employed (2017 - 2026) Analysis & Trends
uniQure's Return on Capital Employed history runs 10 years deep, the most recent figure standing at 7.58% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 2352.0% year-over-year to 7.58%; the TTM figure through Mar 2026 stood at 7.58% (up 2352.0% YoY), while the FY2025 annual figure was 7.95%, up 2023.0% from the prior year.
- Return on Capital Employed was 7.58% for Q1 2026 at uniQure, down from 6.28% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 9.96% in Q1 2022 to a low of 65.21% in Q3 2022.
- Historically, Return on Capital Employed has averaged 21.73% across 5 years, with a median of 23.97% in 2023.
- Biggest YoY gain for Return on Capital Employed was 5228 bps in 2022; the steepest drop was 11285 bps in 2022.
- A 5-year view of Return on Capital Employed shows it stood at 24.03% in 2022, then surged by 58 bps to 10.17% in 2023, then sank by 223 bps to 32.84% in 2024, then jumped by 81 bps to 6.28% in 2025, then dropped by 21 bps to 7.58% in 2026.
- The last three Return on Capital Employed figures came in at 7.58% (Q1 2026), 6.28% (Q4 2025), and 28.31% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | -7.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.58% |
| Dec 31, 2025 | -6.28% |
| Sep 30, 2025 | -28.31% |
| Jun 30, 2025 | -30.54% |
| Mar 31, 2025 | -31.10% |
| Dec 31, 2024 | -32.84% |
| Sep 30, 2024 | 0.58% |
| Jun 30, 2024 | -5.68% |
| Mar 31, 2024 | -8.02% |
| Dec 31, 2023 | -10.17% |
| Sep 30, 2023 | -23.21% |
| Jun 30, 2023 | -23.97% |
| Mar 31, 2023 | -27.13% |
| Dec 31, 2022 | -24.03% |
| Sep 30, 2022 | -65.21% |
| Jun 30, 2022 | -55.88% |
| Mar 31, 2022 | 9.96% |
| Dec 31, 2021 | 11.02% |
| Sep 30, 2021 | 40.72% |
| Jun 30, 2021 | 56.97% |